The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: A first report

Japanese Journal of Infectious Diseases

Volumn 61, Issue 2, 2008, Pages 107-110

  Orrett, Fitzroy A ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; OXACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; GENERAL HOSPITAL; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREVALENCE; SURGICAL INFECTION; TRINIDAD AND TOBAGO;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MUPIROCIN; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRINIDAD AND TOBAGO;

EID: 43449129464     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Emori, T.G. and Gaynes, R.P. (1993): An overview of nosocomial infection, including the role of microbiology laboratory. Clin. Microbiol. Rev., 6, 428-442.
2. Orrett, F.A. (2002): Nosocomial infections in an intensive care unit in a private hospital. West Indian Med. J., 51, 21-24.
3. Orrett, F.A. (1999): Methicillin-resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-β-lactam antibiotics. Jpn. J. Infect. Dis., 52, 238-241.
4. Anupurba, S., Sen, M.R., Nath, G., et al. (2003): Prevalence of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J. Med. Microbiol., 21, 49-51.
5. Blanc, D.S., Pitter, D., Ruef, C., et al. (2002): Epidemiology of methicillin-resistant Staphylococcus aureus: results of a nation-wide survey in Switzerland. Swiss Med. Wkly., 132, 223-229.
6. Saderi, H., Owlia, P. and Shahrbanooie, R. (2005): Vancomycin resistance among clinical isolates of Staphylococcus aureus. Arch. Iranian Med., 8, 100-103.
7. Bell, J.M. and Turnidge, J.D. (2002): SENTRY APAC participants: high prevalence of oxacillin-resistant Staphylococcus aureus isolated from hospital patients in Asia-Pacific and South Africa: results from SENTRY Antimicrobial Surveillance Program, 1998-1999. Antimicrob. Agents Chemother., 46, 879-881.
8. Kuehnert, M.J., Hill, H.A., Kupronis, B.A., et al. (2005): Methicillin-resistant Staphylococcus aureus hospitalization, Uhited States. Emerg. Infect. Dis., 11, 868-872.
9. Jevons, M.P. (1961): "Celbenin"-resistant staphylococci. Br. Med. J., 1, 124-125.
10. Barrett, F.F., McGehee, R.F., Jr. and Finlay, M. (1968): Methicillin-resistant Staphylococcus aureus at Boston City Hospital. N. Engl. J. Med., 279, 441-448.
11. Brown, P.D. and Ngeno, C. (2006): Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica. Int. J. Infect. Dis., 286, 1-6
12. Lee, H.J., Suh, J.T. and Kim, S.Y. (2001): Typing and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus strains isolated in a hospital in Korea. J. Korean Med. Sci., 16, 381-385.
13. Kerttula, A.M., Lyytikainen, O. and Salmenlinna, S. (2004): Changing epidemiology of methicillin-resistant Staphylococcus aureus in Finland. J. Hosp. Infect., 58, 109-114.
14. Bukhari, M.H., Igbal, A., Khatoon, N., et al. (2004): A laboratory study of susceptibility of methicillin-resistant Staphylococcus aureus. Pak. J. Med. Sci., 20, 229-233.
15. Orrett, F.A. and Land, M. (2006): Methicillin-resistant Staphylococcus aureus prevalence: current susceptibility patterns in Trinidad. BMC Infect Dis., 6, 83.
16. Laupland, K.B. and Conly, J.M. (2003): Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin. Infect. Dis., 37, 933-938.
17. Nishijima, S. and Kurokawa, I. (2002): Antimicrobial resistance of Staphylococcus aureus isolated from skin infections. Int J. Antimicrob. Agents, 19, 241-243.
18. Perl, T.M. Cullen, J.J. and Wenzel, R.P. (2002): Mupirocin and the risk of Staphylococcus aureus study team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N. Engl. J. Med., 346, 1871-1877.
19. Rahaman, M., Noble, W.C. and Cookson, B. (1987): Mupirocin-resistant Staphylococcus aureus. Lancet, 2, 387-388.
20. Moorehouse, E., Fenelon, L. and Hone, R. (1996): Staphylicocus aureus sensitivity to various antibiotics-a national survey of Ireland 1993. Irish J. Med. Sci., 165, 40-43.
21. Schmitz, F.-J., Lindenlauf, E., Hofmann, B., et al. (1998): The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J. Antimicrob. Chemother., 42, 489-495.
22. Cookson, B.D. (1998): The emergence of mupirocin resistance: a challenge to infection control and antimicrobial treatment practice. J. Antimicrob. Chemother., 41, 11-18.
23. Nettos dos Santos, K.R., de Souza Fonseca, L. and Gontijo Filho, P.P. (1996): Emergence of high-level mupirocin resistance in MRSA isolates from a Brazilian university hospital. Infect. Control Hosp. Epidemiol., 17, 813-816.
24. Antonio, M., McFerran, N. and Pallen, M.J. (2002): Mutations affect the Rossman fold of isoleucyl t-RNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother., 46, 438-442.
25. Hefferman, H., Davies, H. and Brett, M. (1995): Methicillin-resistant Staphylococcus aureus in New Zealand. N.Z. Public Health, 2, 97-99.
26. Irizarry, L., Rupp, J. and Griffith, J. (1996): Frequency of high-level mupirocin-resistant Staphylococcus aureus in a tertiary care facility (letter). Antimicrob. Agents Chemother., 40, 1967-1968.
27. Clinical and Laboratory Standards Institute (2006): Performance standard for antimicrobial disk susceptibility testing. Approved standard. 9th ed. M2-A9, vol. 26, no. 1. Clinical and Laboratory Standards Institute,, Wayne, Pa.
28. Finlay, J.E., Miller, L.A. and Poupard, J.A. (1997): Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob. Agents Chemother., 41, 1137-1139.
29. Leski, T.A., Gniadkowski, M., Skoczynska, A., et al. (1999): Outbreak of mupirocin resistant staphylococci in a hospital in Warsaw, Poland, due to plasmid transmission and clonal spread of several strains. J. Clin. Microbiol., 37, 2781-2788.
30. Gadepalli, R., Dhawan, B., Mohanty, S., et al. (2007): Mupirocin resistance in Staphylococcus aureus in an Indian hospital. Diagn. Microbiol. Infect. Dis., 58, 125-127.
31. Vasquez, J.E., Walker, E.S., Franzus, B.W., et al. (2000): The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a veterans affairs hospital. Infect. Control Hosp. Epidemiol., 21, 459-464.
32. Walker, E.S., Vasquez, J.E., Dala, R., et al. (2003): Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective? Infect. Control Hosp. Epidemiol., 24, 342-346.
33. Smith, G.E. and Kennedy, C.T.C. (1988): Staphylococcus aureus resistant to mupirocin. J. Antimicrob. Chemother., 21, 141-142.
34. Cookson, B.D. (1990): Mupirocin resistance in Staphylococcus aureus. J. Antimicrob. Chemother., 25, 497-501.
35. Irish, D., Eltringham, I., Teall, A., et al. (1998): Control of an outbreak of an epidemic methicillin and mupirocin-resistant Staphylococcus aureus. J. Hosp. Infect., 39, 19-26.
36. Poupard, J.A. (1995): Update on mupirocin resistance, J. Chemother., 7 (Suppl. 3), 71-74.
37. Kauffman, C.A., Terpenning, M.S., He, X., et al. (1993): Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term care facility with the use of mupirocin ointment. Am. J. Med., 94, 371-378.